Detalhe da pesquisa
1.
Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial.
Hum Vaccin Immunother
; 17(7): 2107-2116, 2021 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626291
2.
Optimized enzyme-linked immunosorbent assay for detecting cytomegalovirus infections during clinical trials of recombinant vaccines.
J Clin Virol
; 96: 99-104, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29035763
3.
Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore.
Hum Vaccin Immunother
; 9(11): 2317-25, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23839107